Key facts
- Glycolink’s last known valuation is $1.8M (Dec 2024).
- It has raised $190K.
- Notable investors include Stockholm Innovation & Growth, KTH Holding.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Glycolink
- ·The full record, as it builds
Funding rounds
No funding rounds for Glycolink are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Glycolink
Developer of hydrogel designed to offer skin care products made with natural ingredients. The company's hydrogels are made with bio-based components that are biodegradable and derived from safe natural microorganisms, and biocompatible and tunable, enabling pharmaceutical businesses to develop and produce chemicals-free skin care products at low costs.
- Sector
- Materials and Resources
- HQ
- Stockholm, Sweden
- Founded
- 2020
- Employees
- 7
- Website
- glycolink.com/
- Ownership
- Privately Held (backing)
Glycolink doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Glycolink shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Glycolink in its N-PORT filings yet. We sweep new filings monthly.